Meeting
2015 ASCO Annual Meeting
Long-term survival in patients with primary CNS lymphoma: Results from the G-PCNSL-SG1 trial.
Authors
Patrick Roth
Department of Neurology, University Hospital Zurich, Zurich, Switzerland
Patrick Roth , Peter Martus , Eckhard Thiel , Agnieszka Korfel , Michael Weller
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 33, 2015 (suppl; abstr 2032)
DOI
10.1200/jco.2015.33.15_suppl.2032
Abstract #
2032
Poster Bd #
21
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
MTHFR polymorphisms and neurotoxicity and overall survival after methotrexate-based therapy in primary CNS lymphoma.
First Author: Philipp Karschnia
Poster
2016 ASCO Annual Meeting
Outcomes and prognostic factors of radiotherapy with dexamethasone, etoposide, ifosfamide, and carboplatin (RT-DeVIC) for newly diagnosed, localized extranodal NK/T-cell lymphoma, nasal type (ENKL): a cooperative study in Japan.
First Author: Motoko Yamaguchi
Poster
2015 ASCO Annual Meeting
Patterns of response and relapse of primary central nervous system lymphomas (PCNSL) following first line of high-dose methotrexate-based chemotherapy (hdMTX): Analysis of a prospective ANOCEF randomized phase II trial.
First Author: Emeline Tabouret
Poster
2015 ASCO Annual Meeting
GLIOSTRY (GLIOblastoma regiSTRY) of the AINO (Italian Association of Neuro-Oncology): Analysis of factors influencing survival in glioblastoma patients receiving the nitrosourea fotemustine at first relapse following Stupp regimen.
First Author: Roberta Ruda